Is A Short Squeeze Ahead for Onconova (ONTX)?

Zacks

Many investors appear to be quite bearish on Onconova Therapeutics Inc. (ONTX), especially if you look at the percentage of the float that is sold short for this stock. Currently, 20.3% of the float is sold short, suggesting an extreme level of bearishness for ONTX.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we have a Zacks Rank #2 (Buy) on ONTX, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of ONTX to move higher in the weeks ahead.



ONCONOVA THERAPEUTICS INC (ONTX): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)